# Cibus, Inc.: overview CBUS · Nasdaq · CIK 1705843 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/cbus.md) · [Financials](/companies/cbus/financials.md) · [Filings](/companies/cbus/filings.md) · [Insiders](/companies/cbus/insiders.md) Latest reported revenue: [$994.0k](/filings/0001628280-26-056773.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-056773). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1.7](/filings/0001628280-25-052072.md) | [1.2 d](/filings/0001628280-26-018815.md) | [1.0](/filings/0001628280-26-035159.md) | [0.9](/filings/0001628280-26-056773.md) | [0.6](/filings/0001628280-25-052072.md) | [1.1 d](/filings/0001628280-26-018815.md) | [1.7](/filings/0001628280-26-035159.md) | [1.0](/filings/0001628280-26-056773.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(12023.8%)](/filings/0001628280-25-052072.md) | [(1487.1%) d](/filings/0001628280-26-018815.md) | [(4020.4%)](/filings/0001628280-26-035159.md) | [(1923.5%)](/filings/0001628280-26-056773.md) | [(2510.2%)](/filings/0001628280-25-052072.md) | [(2135.7%) d](/filings/0001628280-26-018815.md) | [(721.0%)](/filings/0001628280-26-035159.md) | [(1300.3%)](/filings/0001628280-26-056773.md) | | Net margin | % | [(10795.9%)](/filings/0001628280-25-052072.md) | [(1906.1%) d](/filings/0001628280-26-018815.md) | [(4534.4%)](/filings/0001628280-26-035159.md) | [(2719.4%)](/filings/0001628280-26-056773.md) | [(3827.8%)](/filings/0001628280-25-052072.md) | [(2959.9%) d](/filings/0001628280-26-018815.md) | [(1262.5%)](/filings/0001628280-26-035159.md) | [(2227.9%)](/filings/0001628280-26-056773.md) | | Diluted EPS | $ per share | [(7.63)](/filings/0001628280-25-052072.md) | not reported | [(1.34)](/filings/0001628280-26-035159.md) | [(0.61)](/filings/0001628280-26-056773.md) | [(0.44)](/filings/0001628280-25-052072.md) | not reported | [(0.33)](/filings/0001628280-26-035159.md) | [(0.29)](/filings/0001628280-26-056773.md) | | Free cash flow | $m | [(13.9) d](/filings/0001628280-25-052072.md) | [(14.1) d](/filings/0001628280-26-018815.md) | [(12.1)](/filings/0001628280-26-035159.md) | [(13.7) d](/filings/0001628280-26-056773.md) | [(11.8) d](/filings/0001628280-25-052072.md) | [(13.5) d](/filings/0001628280-26-018815.md) | [(11.6)](/filings/0001628280-26-035159.md) | [(9.5) d](/filings/0001628280-26-056773.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [26.0](/filings/0001193125-23-060159.md) | [0.2](/filings/0001628280-24-012546.md) | [1.8](/filings/0001628280-25-014139.md) | [4.3](/filings/0001628280-26-018815.md) | [3.6](/filings/0001628280-26-018815.md) | | Gross margin | % | [(9.9%)](/filings/0001193125-23-060159.md) | [100.0%](/filings/0001193125-23-060159.md) | not reported | not reported | not reported | | Operating margin | % | [(112.9%)](/filings/0001193125-23-060159.md) | [(14248.4%)](/filings/0001628280-24-012546.md) | [(17550.0%)](/filings/0001628280-25-014139.md) | [(6062.8%)](/filings/0001628280-26-018815.md) | [(2680.1%)](/filings/0001628280-26-018815.md) | | Net margin | % | [(112.4%)](/filings/0001193125-23-060159.md) | [(10758.6%)](/filings/0001628280-24-012546.md) | [(14729.1%)](/filings/0001628280-25-014139.md) | [(5898.4%)](/filings/0001628280-26-018815.md) | [(3492.3%)](/filings/0001628280-26-018815.md) | | Diluted EPS | $ per share | [(0.78)](/filings/0001193125-23-060159.md) | [(18.36)](/filings/0001628280-24-012546.md) | [(25.95)](/filings/0001628280-25-014139.md) | [(10.83)](/filings/0001628280-26-018815.md) | [(2.78)](/filings/0001628280-26-018815.md) | | Free cash flow | $m | [(19.3)](/filings/0001193125-23-060159.md) | [(20.9)](/filings/0001628280-24-012546.md) | [(50.5)](/filings/0001628280-25-014139.md) | [(58.9)](/filings/0001628280-26-018815.md) | [(51.2)](/filings/0001628280-26-018815.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cbus/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [FMR LLC](/funds/315066.md) | 2026-06-30 | $15.7m | 11,449,660 | | Added +23,731 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.2m | 2,299,966 | | Added +181,470 | | [UNITED CAPITAL FINANCIAL ADVISORS, LLC](/funds/1463217.md) | 2026-06-30 | $789.2k | 576,043 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $723.9k | 528,233 | | Added +45,324 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $675.1k | 492,795 | | Added +77,619 | | [Coppell Advisory Solutions LLC](/funds/1848433.md) | 2026-06-30 | $465.2k | 250 | | New +250 | | [CERTIOR FINANCIAL GROUP, LLC](/funds/2055620.md) | 2026-06-30 | $462.7k | 337,710 | | Added +19,507 | | [Prescott Group Capital Management, L.L.C.](/funds/1166152.md) | 2026-06-30 | $449.6k | 328,157 | | Unchanged | | [Squarepoint Ops LLC](/funds/1642575.md) | 2026-06-30 | $427.9k | 312,340 | | Added +237 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $424.9k | 310,136 | | Added +51,988 | ## Recent filings [All 710 filings](/companies/cbus/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-13 | 16:32 ET | [10-Q](/filings/0001628280-26-056773.md) | Quarterly report, period 2026-06-30 | 0001628280-26-056773 | | 2026-08-13 | 16:14 ET | [8-K](/filings/0001628280-26-056731.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-056731 | | 2026-06-09 | 08:19 ET | [8-K](/filings/0001628280-26-041775.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-041775 | | 2026-06-05 | 08:45 ET | [8-K](/filings/0001628280-26-041069.md) | 5.07 Shareholder vote results | 0001628280-26-041069 | | 2026-05-14 | 16:40 ET | [10-Q](/filings/0001628280-26-035159.md) | Quarterly report, period 2026-03-31 | 0001628280-26-035159 | | 2026-05-14 | 16:11 ET | [8-K](/filings/0001628280-26-035105.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-035105 | | 2026-04-20 | 16:35 ET | [DEF 14A](/filings/0001628280-26-026011.md) | Proxy statement, period 2026-06-02 | 0001628280-26-026011 | | 2026-04-10 | 17:06 ET | [8-K](/filings/0001628280-26-024746.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-024746 | | 2026-03-27 | 08:45 ET | [8-K](/filings/0001193125-26-127706.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-127706 | | 2026-03-17 | 16:36 ET | [10-K](/filings/0001628280-26-018815.md) | Annual report, period 2025-12-31 | 0001628280-26-018815 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-018815.md), filed Mar 17, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/5c99ad4d-f491-4bd7-a55c-edd78469ab87) ## About the filer - CIK: 1705843 - Tickers: CBUS - Exchange: Nasdaq - SIC code: 2870 Agricultural Chemicals - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.